Travere Therapeutics, Inc.
TVTX
60 insider filings · Latest: Sep 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | Feb 4 2:30 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Sale | 7,310 | $32.12 | $234.8K | 131,823(D) | View → |
| Feb 3, 2026 | Feb 4 2:30 AM | William E. RoteChief Research Officer | Sale | 12,446 | $32.87 | $409.1K | 109,087(D) | View → |
| Feb 3, 2026 | Feb 4 2:30 AM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Sale | 4,333 | $32.12 | $139.2K | 49,080(D) | View → |
| Feb 3, 2026 | Feb 4 2:30 AM | Elizabeth E ReedChief Legal Officer and GC | Sale | 7,175 | $32.12 | $230.5K | 108,205(D) | View → |
| Feb 3, 2026 | Feb 3 4:38 PM | Dube Eric M | Proposed Sale | 100,087 | $32.87 | $3.3M | — | View → |
| Feb 3, 2026 | Feb 3 3:05 PM | ROTE WILLIAM E. | Proposed Sale | 12,446 | $32.87 | $409.1K | — | View → |
| Jan 27, 2026 | Jan 28 1:25 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 51,865 | $30.10 | $1.6M | 419,173(D) | View → |
| Jan 23, 2026 | Jan 28 1:25 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 8,135 | $30.01 | $244.2K | 419,173(D) | View → |
| Jan 27, 2026 | Jan 27 9:05 PM | Dube Eric M | Proposed Sale | 51,865 | $30.10 | $1.6M | — | View → |
| Jan 23, 2026 | Jan 23 9:14 PM | Dube Eric M | Proposed Sale | 8,135 | $30.01 | $244.2K | — | View → |
| Jan 20, 2026 | Jan 21 9:05 PM | Elizabeth E ReedChief Legal Officer and GC | Sale | 10,000 | $27.34 | $273.4K | 90,270(D) | View → |
| Jan 20, 2026 | Jan 20 9:04 PM | ELIZABETH REED | Proposed Sale | 10,000 | $27.34 | $273.4K | — | View → |
| Jan 6, 2026 | Jan 6 9:07 PM | JULA INRIG | Proposed Sale | 445 | $37.75 | $16.8K | — | View → |
| Jan 5, 2026 | Jan 6 12:49 AM | Jula Inrig | Proposed Sale | 2,031 | $40.18 | $81.6K | — | View → |
| Dec 24, 2025 | Dec 29 2:39 PM | JULA INRIG | Proposed Sale | 15,000 | $42.00 | $630.0K | — | View → |
| Dec 24, 2025 | Dec 29 2:38 PM | SANDRA CALVIN | Proposed Sale | 7,402 | $40.00 | $296.1K | — | View → |
| Dec 24, 2025 | Dec 29 11:58 AM | Heerma Peter | Proposed Sale | 4,980 | $40.00 | $199.2K | — | View → |
| Dec 24, 2025 | Dec 29 11:28 AM | ROTE WILLIAM E. | Proposed Sale | 60,000 | $40.10 | $2.4M | — | View → |
| Dec 15, 2025 | Dec 15 9:05 PM | SANDRA CALVIN | Proposed Sale | 2,910 | $36.00 | $104.8K | — | View → |
| Dec 1, 2025 | Dec 1 9:09 PM | CHRISTOPHER CLINE | Proposed Sale | 20,000 | $35.01 | $700.2K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | May 21 9:00 PM | John A OrwinDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Meckler Jeffrey ADirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | LYONS GARY ADirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Timothy CoughlinDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Suzanne Louise BruhnDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Roy D. BaynesDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 5, 2026 | May 7 12:00 AM | Roy D. BaynesDirector | Option Exercise | 4,500 | $18.27 | 0(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Meckler Jeffrey ADirector | Option Exercise | 8,000 | $16.33 | 0(D) | View → |
| May 4, 2026 | May 7 12:00 AM | William E. RoteChief Research Officer | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | William E. RoteChief Research Officer | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Elizabeth E ReedChief Legal Officer and GC | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 24,250 | $17.96 | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Jula InrigCHIEF MEDICAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Jula InrigCHIEF MEDICAL OFFICER | Option Exercise | 24,250 | $22.40 | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 22,500 | — | 22,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 45,000 | — | 45,000(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |